Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by GameChangerBeton May 13, 2021 3:41pm
228 Views
Post# 33196616

RE:RE:Share price taken down

RE:RE:Share price taken down
MrMugsy wrote:
woundedknee wrote:
By suspicious actions. Very low trading which leads me to believe this is totally manipulated by one or two traders or brokerage houses. I would be concerned if there were hundreds of thousands or millions of shares traded daily, but this is not the case. So if you shorters or MMs want to play this game then go for it..I will buy more as you take it down. As an observation over the past several years I firmaly believe that manipulators just snub their noses at regulators, because they know most times they get away with breaking all the rules. I could say more, but I won't. gl


Exactly.
They take it down, we're ready with cash to buy what we believe to be cheap ... and the future winners.  That's the only game I've ever really played.


If you're willing to give this enough time, by that I mean 2-3 years, the only thing that's essentially going to matter is whether or not this product will ultimately get to market. With all the information I'm aware of, Phase l and phase ll results, Nuance believing as such, FDA's approval to proceed, I find it hard to find any evidence to the contrary.

Phase lll will have a sample size that will include a longer duration to reach a conclusion, which can produce results that were not seen in the previous trials, but it doesn't seem that there will be any negative surprises. That's just based on what is known so far. But the conviction of all those involved seems to be pretty high.
<< Previous
Bullboard Posts
Next >>